\
&
Contact us
Published on | 2 months ago
ProgrammesThe Marie Sklodowska-Curie Actions (MSCA) Radiance NCP network has updated and published support material which is available for National Contact Points (NCPs) and applicants:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Culture and society Climate, Energy, Mobility EIC
OASC (Open & Agile Smart Cities & Communities) is a partner in the ACCEND project, a Europe-wide project building the foundations for a stronger, more connected deep tech scaleup scene. If you're developing solutions for Smart Cities, Net Zero Cities or Regenerative Cites, you might be interested in this opportunity to accelerate your... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.